Work

The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery

Year: 2026
Type: review
Abstract: CAR-T generation. Our central thesis is that the next generation of viral medicines will be selected not by the most elaborate genome, but by the most coherent alignment of five measurable success factors: tumor selectivity, immune remodeling, delivery and biodistribution, controllable safety, and manufacturability. The emerging paradigm is therefore programmable viral therapeutics: context-sensitive biological medicines designed to operate within the constraints of human tumors and human immunity.
Source: RSC Advances
Language: English
Subfield: Genetics
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7225648891
FWCI:
Cites: 120
Cited by:
Related to: 10